Background Published data imply that adult concentrations are achieved for all Ig isotypes and plateau by 15--18 years of age. Recent data, however, suggest that these results are not applicable in the elderly. There are no equivalent data for IgG subclasses. We present reference range data for an elderly UK patient population, for IgG, IgA, IgM and IgG subclasses.
Introduction
The changes in Ig concentrations in children are well understood and reference ranges are widely available. 1 However, implicit in much of the published data is the principle that adult concentrations are achieved for all isotypes and reach a stable plateau by around 15^18 years of age. 1^3 A recent study of a very large cohort has contradicted this. 4 These data suggest that median concentrations of IgA continue to rise in the age range 20^100 years, that IgG essentially remains unchanged, and that IgM declines. There are no equivalent data for IgG subclass concentrations, but on the basis of the data of Ritchie et al., 4 one would predict that these too would be relatively stable in the elderly. In both the inpatient and outpatient settings, with improving life expectancies, an increasing proportion of the patients under investigation are more than 60 years of age.
Laboratory precision in this area is important for several reasons, including, for example, the issue of whether individuals with`low' Ig concentrations merit further investigation, for example owing to the suspicion of immune paresis secondary to haematological malignancy. Of greater concern is anecdotal experience of expensive and potentially dangerous blood donor-derived intravenous Ig replacement therapy being considered inappropriately, in order to reduce the perceived risk of bacterial respiratory or other infection in elderly patients with borderline serum IgG concentrations.
In our own practice we too have observed that the standard adult reference ranges do not apply to the elderly population. Here we present reference range data for an elderly UK patient population, for IgG, IgA, IgM and IgG subclasses.
Methods
Data were collected on 1146 consecutive serum samples from patients aged 61 years or more (575 men, 571 women) and on 925 patients aged 18^60 years
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(450 men, 475 women) who had been referred routinely for Ig analysis during 2000. Similarly, data were collected on 498 consecutive serum samples from patients aged 61 years or more (255 men, 243 women) and on 484 patients aged 18^60 years (220 men, 264 women) who had been referred routinely for Ig subclass analysis between 1998 and 2001. All specimens included for analysis were the ¢rst received on each patient during the period, duplicates being excluded.
All Igs and subclasses were measured by nephelometry according to the manufacturer's instructions (BN2 nephelometer, Dade Behring GmbH, Marburg, Germany). IgG, IgA and IgM were calibrated against reference material CRM 470. IgG subclasses were calibrated against WHO 67/97, using the assigned values from Klein et al. 5 Between-batch variations for these assays were all between 3% and 6%.
For statistical analysis patients were divided into three age groups: 18^60 years, 61^70 years and more than 70 years. Reference populations were determined by probability plotting of log transformed data. This technique isolates log-normally distributed subpopulations from within a mixed population. An example of this type of analysis is given in Figure 1 for serum IgG in women aged18^60 years.`High'and`low' populations were excluded, leaving a`normal range' (the reference population).
Using the reference populations as de¢ned above, non-parametric analysis (`median test' using w 2 Analyse-It version 1.62, Analyse-It Software Ltd, UK) was used to determine whether the medians were dependent on age. Data were also examined within each age band for di¡erences between male and female reference ranges. Statistical signi¢cance was assumed if P50Í05.
Reference ranges were de¢ned non-parametrically as the 2Í5th to 97Í5th centiles of the reference populations.
Results
Reference ranges and medians for the patient groups for serum IgA, IgM and IgG are shown in Figure 2 , and for serum IgG 1 , IgG 2 and IgG 3 in Figure 3 . Reference ranges are shown in Table 1 . IgG 4 values frequently fell below the level of detection, making a lower reference limit indeterminable. It was, however, possible to demonstrate that the median IgG 4 was not agedependent, neither for women (Pˆ0Í35) nor men (Pˆ0Í85). Patients with haematological malignancies (myeloma, macroglobulinaemia) formed a minor population within the groups (18^60 years 2%, 61^70 years 5%, 71 years and over 6Í6%).
Data were analysed to determine whether median concentrations for each age group were dependent on gender. Few di¡erences were seen. Median IgM was signi¢cantly lower in men than in women in the younger age groups (18^60 years P50Í001; 61^70 years Pˆ0Í017). Median IgG and IgG 4 were signi¢cantly higher in men than in women in the over-71-year-old group (Pˆ0Í023 and Pˆ0Í045, respectively). No other gender-dependent di¡erences in medians were seen.
Discussion
It can be argued that a patient base-derived reference range is representative of the population of interest, as distinct from a self-selected healthy population (e.g. blood donors), and is therefore of more direct clinical relevance. Additionally, in the UK, blood donors are aged less than 60 years, and obtaining a`normal' elderly cohort is very di¤cult. Whereas Ritchie et al. 4 derived their reference ranges from selected patientbased data by extensive examination of their patients' records, we allowed the probability plotting method to One potentially confounding in£uence on our approach is the presence of paraproteinaemia and immune paresis associated with haematological malignancy. However, our data showed that these do not a¡ect the`break points' used to determine the high and low populations. The majority appear as outliers at the far ends of these distributions. Several points of this nature, both high and low, may be seen in Figure 1 . Other benign paraproteins (monoclonal gammopathy of undetermined signi¢cance, connective tissue disorders or chronic infection) often fell within the reference range and were not associated with immune paresis. Thus, these do not appear to have a signi¢cant e¡ect on the data. Additionally, the patient mix also includes signi¢cant populations of patients with polyclonal hypergammaglobulinaemia (liver disease, connective tissue disorders, chronic infection) and hypogammaglobulinaemia (predominantly common variable immunode¢ciency), all of which helps to de¢ne the abnormal populations.
Our data con¢rm that serum IgM concentrations are signi¢cantly reduced in the elderly, whereas serum IgA concentrations are maintained. Indeed, males showed a slight but signi¢cant increase in median serum IgA with age. In contrast to Richie et al., we found that median serum IgG is also reduced in the elderly (470 years). More importantly, not only are medians reduced in the elderly, but for many analytes the lower reference limit is also reduced. It is these that will in£uence clinical decisions in terms of further investigation and possible therapy. Both our data and those of Ritchie et al. show that the lower end of the IgG reference range is reduced in the elderly.
In addition, we present here data on IgG subclass reference ranges in the elderly. Of particular note are the age-related changes in IgG 2 . Although the median is relatively stable in women, the upper limit of the reference range for IgG 2 is reduced over 60 years of age (see Fig. 3 ). In elderly men this is more marked; not only is the upper limit of IgG 2 reduced, but medians are also reduced. These ¢ndings are in contrast to the only other study speci¢cally determining IgG subclasses in an elderly population. 5 This showed increased IgG in very elderly persons (over 95 years of age, in contrast to the present study, in which only three patients over 90 years were included), with a concomitant rise in IgG 1 and IgG 3 . It should be noted that this early study investigated a relatively small cohort of 73 volunteers, of whom 19% had paraproteinaemia and were excluded from the analysis.
Two major sources are quoted as assigning values to the WHO reference material. 6, 7 Whereas the assigned values for IgG 1 and IgG 2 are similar, those for IgG 3 and IgG 4 are signi¢cantly di¡erent. This enhances the need for local reference ranges to be established in each centre. Indeed, there is a need to establish local, method-dependent normal ranges for all Ig assays, which may be signi¢cantly at variance with published data (e.g. the Protein Reference Units Handbook 1 ).
Ritchie et al. highlighted gender-related di¡erences in their population. Although we also see genderrelated di¡erences, these only achieve statistical signi¢cance in a minority of the groups studied. Of note was the lower reference range for women over 70 years of age for total IgG and, within that, for the IgG 1 subclass.
Apparently low Ig concentrations in the elderly may be found in four major contexts: haematological malignancy with associated paresis; true immuno -de¢ciency; as an incidental ¢nding unrelated to symptoms; and falsely low values owing to an inappropriately assigned reference range. The ¢rst category can be detected by serum electrophoresis. Of more concern are the last two categories, which can lead to over-investigation.
Age-and gender-related di¡erences in the Igs and IgG subclasses have important implications. In particular, we have noted that many patients with chronic respiratory and other infections are extensively investigated for underlying immune compromise, with associated investment in time Table 1 . Summary of age-and gender-related reference ranges (2 ¢ 5th--97 ¢ 5th centiles) of reference population as de ned by probability plotting (see Figure 1 for example). The lower limit of the reference range for IgG 4 
was not determinable, owing to the detection limit of assay
Women Men Age (years) 18--60 61--70 71 ‡ 18--60 61--70 71 ‡ IgA (g/L) 1¢10--3¢57 1¢09--3¢77 0¢89--3¢64 0¢98--3¢55 0¢78--3¢85 0¢89--4¢65 IgM (g/L) 0¢60--2¢21 0¢32--1¢73 0¢39--1¢93 0¢57--2¢21 0¢30--1¢72 0¢37--1¢90 IgG (g/L) 8¢0--15¢6 7¢3--15¢8 5¢7--12¢2 8¢3--16¢7 6¢5--15¢6 5¢9--15¢4 IgG 1 (g/L) 4¢35--9¢55 4¢20--10¢68 3¢61--8¢70 4¢10--8¢90 3¢61--8¢90 3¢53--8¢73 IgG 2 (g/L)
1¢18--4¢66 1¢25--4¢03 1¢23--3¢87 1¢42--4¢72 1¢35--3¢87 1¢44--2¢99 IgG 3 (g/L) 0¢13--0¢62 0¢18--0¢88 0¢16--0¢69 0¢19--0¢85 0¢18--0¢64 0¢18--0¢64 IgG 4 (g/L) --1¢08 --0¢69 --0¢70 --1¢18 --1¢16 --1¢06 and resources. Thus, without the age-and gender-adjusted ranges for IgG, an 80-year-old with serum IgG concentration of 6Í0 g/L would be falsely assigned as hypogammaglobulinaemic, prompting extensive further investigation and, potentially, inappropriate replacement Ig therapy. In order to avoid this, we advocate that centres o¡ering these investigations provide local, methoddependent reference ranges, and have suggested an approach as to how this might be achieved.
